Login / Signup
Nezam H Afdhal
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 7
Top Topics
Clinical Trial
Liver Fibrosis
Magnetic Resonance
Label Free
Top Venues
Hepatology communications
International journal of hepatology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Stephen Caldwell
,
Alnoor Ramji
,
Tarek Hassanein
,
Eric M Yoshida
,
Emily Pang
,
Caitlin Schneider
,
Michael P Curry
,
Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD.
Hepatology communications
8 (4) (2024)
Stephen Caldwell
,
Alnoor Ramji
,
Tarek Hassanein
,
Eric M Yoshida
,
Emily Pang
,
Caitlin Schneider
,
Michael P Curry
,
Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD.
Hepatology communications
8 (4) (2024)
Stephen Caldwell
,
Alnoor Ramji
,
Tarek Hassanein
,
Eric M Yoshida
,
Emily Pang
,
Caitlin Schneider
,
Michael P Curry
,
Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD.
Hepatology communications
8 (4) (2024)
Michael P Curry
,
Edward Tam
,
Caitlin Schneider
,
Noha Abdelgelil
,
Tarek Hassanein
,
Nezam H Afdhal
The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study.
International journal of hepatology
2024 (2024)
Stephen Caldwell
,
Alnoor Ramji
,
Tarek Hassanein
,
Eric M Yoshida
,
Emily Pang
,
Caitlin Schneider
,
Michael P Curry
,
Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD.
Hepatology communications
8 (4) (2024)
Michael P Curry
,
Edward Tam
,
Caitlin Schneider
,
Noha Abdelgelil
,
Tarek Hassanein
,
Nezam H Afdhal
The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study.
International journal of hepatology
2024 (2024)
Stephen Caldwell
,
Alnoor Ramji
,
Tarek Hassanein
,
Eric M Yoshida
,
Emily Pang
,
Caitlin Schneider
,
Michael P Curry
,
Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD.
Hepatology communications
8 (4) (2024)